Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By white_Tiger (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Model Portfolio 🚨: Will SYRA Qualify As GeoInvesting’s Next Run to $1.00 Addition? [GeoWire Weekly No. 242]

% of readers think this story is Fact. Add your two cents.



If you are a premium member make sure you sign in to see All the exclusive content In This Issue.

This week’s Microcap Information Arbitrage Weekly Wrap-Up is ready — spotlighting the most important developments across our 1,500+ microcap coverage universe built since 2009, including high-impact earnings reports, information arbitrage discoveries, contract announcements, and model portfolio updates. We also highlight insights from our investor and CEO interviews (Skull Sessions).

See all emails sent during the week here.

As usual, we highlight the stocks we want to watch most in our big movers and losers list of the week, included at the end of this post.

This week’s Feature highlights a Run-to-One candidate from last week’s June Open Forum. 

Stocks discussed at Geoinvesting last week: 

Feature Stock: SYRA, a company that  provides technology healthcare solutions to help improve patient care, turned its first profit. Trading under $1.00 we are attempting to determine if this milestone is sustainable. 

Earnings: HYDTF (TSXV:NURS) URLOF (CSE:URL)

InfoArb Tear Sheets: ITRN SNT BLMWF (TSXV:BLM) PKE BDCTF (TSXV:BILD) SOTK ALAR HYDTF (TSXV:NURS) RMCF PYYX IVFH

Skull Sessions: ‘You Make The Call’ with SYRA Management

Open Forum Feature Stocks: KLNG FTLF SIF HMFAF (TSX:HMM-A) TGEN TPC NSYS TOYO


***In case you missed last week’s Wrap-up, it’s available here***

Last week, we held our June Open Forum. To start things off, we hosted Syra Health Corp. (OTCQB:SYRA) where we discussed its first profitable quarter and its positioning within value-based healthcare, including the behavioral health platform driving its recurring revenue angle. SYRA provides technology healthcare solutions to help improve patient care. More about this later, but you can see the full Open Forum here.

Feature Highlight From Our Microcap Coverage Universe

We opened the June Open Forum with Syra Health Corp. (OTCQB:SYRA) (health technology). SYRA is our fifth “You Make The Call” Skull Session. “You Make The Call” takes a deep dive into speculative companies that we are evaluating to determine whether we can become comfortable covering the story for the GeoInvesting community. The company recently reported its first profitable quarter, with sales of $2.3 million versus $1.9 million last year, and EPS moving to $0.02 from a loss of $0.04.

That profitability marker gave us a reason to dig further into the story. SYRA has a tight capital structure, improving margins, and a business model tied to healthcare technology services focused on improving patient outcomes. It also appears that the company may not need to raise money anytime soon.

Inside this Week’s Report:

  1. Earnings Reports Worth Monitoring
  2. Latest InfoArb Tear Sheets
  3. Skull Sessions
  4. Open Forum Highlights
  5. Coverage Universe Stats: Big Movers & Losers and New Highs & Lows

Earnings Reports Worth Monitoring

Hydreight Technologies Inc (OTCQB:HYDTF) (TSXV:NURS) (telemedicine platform) (Press Release Link) (Morning Email Link)

HYDTF reported Q1 results that came in at the high end of prior guidance, with record revenue and a third consecutive quarter of adjusted EBITDA margin expansion. The company reaffirmed it remains on track to deliver against full-year 2026 guidance, which called for $150 million in revenue, a figure that significantly exceeded the analyst consensus of $105 million when it was first issued in February. 

Namesilo Technologies Corp. (OOTC:URLOF) (CSE:URL) (domain registration) (Press Release Link) (Morning Email Link)

Namesilo Technologies Corp. (OOTC:URLOF) posted record Q1 revenue and gross profit. However, adjusted EBITDA declined from $2.0 million to $1.1 million, driven by increased product development spending within NameSilo LLC and its SewerVue subsidiary. 

Management characterized 2026 as a deliberate year of investment, citing the planned public listings of Alchemy Labs and Ola Media and the continued buildout of SewerVue Technologies and Reach Systems as the primary drivers of elevated near-term costs.

You can read more on what we had to say about these companies at this link, where we archive all of our morning emails


latest InfoArb tear Sheets

In this section of the weekly wrap-up, we will include links to new InfoArb Tear Sheets and to save you time, alert you of any enticing InfoArb we found.


Skull Session – ‘You Make the Call’ with SYRA Management

A Run-to-One Candidate With a Profitability Milestone

We opened the June Open Forum with Syra Health Corp. (OTCQB:SYRA) (health technology). SYRA is our fifth “You Make The Call” Skull Session. “You Make The Call” takes a deep dive into speculative companies that we are evaluating to determine whether we can become comfortable covering the story for the GeoInvesting community.

That profitability marker gave us a reason to dig further into the story. SYRA has a tight capital structure, improving margins, and a business model tied to healthcare technology services focused on improving patient outcomes. It also appears that the company may not need to raise money anytime soon.

Patient Outcomes, Value-Based Care, and Where SYRA Fits

Greg Alexander, CEO of SYRA, framed the company around a healthcare system that is increasingly being pushed to prove outcomes. He discussed how Medicare, Medicaid, and state programs are tying more payments to quality metrics, cost control, and evidence that care programs are producing results.

That backdrop helped explain where the company is trying to fit. The company works with states, local governments, health plans, health systems, providers, and value-based care organizations. Its services include population health analysis, epidemiology, public health assessments, staffing and training, and technology products.

Greg was also clear about the company’s competitive approach. SYRA is not trying to compete directly with the largest healthcare platforms across every category. Instead, the company is focusing on specific areas where it can win, with mental and behavioral health standing out as a key focus.

Serenity, Recurring Revenue, and Growth Priorities

A large part of the conversation focused on Serenity, SYRA’s mental and behavioral health platform. Greg described Serenity as a subscription product, which gives the company an ongoing revenue stream and could help make customer relationships more durable over time.

The platform is designed to support health plans, health systems, and other organizations managing behavioral health needs. Greg also discussed how Serenity could be used with telehealth partners, rural health programs, and, eventually, large self-insured employers.

The company has no debt, has been holding the line on operating expenses, and has no near-term capital expenditure needs this year. The focus now is on organic revenue growth, expanding customer relationships, and building a commercial sales engine.

Government Funding Risk and Customer Expansion

We also spent time on the risk tied to government and state funding. Greg acknowledged that changes in political priorities affected some prior revenue opportunities but said he believes much of that shift has already taken place.

He pointed to multi-year contracts, existing customer relationships, and rural health transformation opportunities as reasons he feels comfortable with the revenue base. He also said those same relationships are giving SYRA more opportunities to get in front of customers and discuss additional programs.


Open Forum Highlights
Model Portfolio Review and Shifting Conviction

After the SYRA segment, we moved the Open Forum discussion to providing updates on the Geoinvesting model portfolios. The Buy on Pullback portfolio had finally recovered into positive territory, while the Focus Model Portfolio underperformance remained centered on longer-term ideas where we are trying to let the thesis develop over time.

We spent time walking through several current holdings and how conviction has shifted. Koil Energy Solutions, Inc. (OTCQB:KLNG) (subsea energy services) remains a longer-term subsea services idea where contract flow has improved visibility, although the margin profile still needs to play out more clearly.

Fitlife Brands, Inc. (NASDAQ:FTLF) (nutritional supplements) was discussed as a name facing some short-term issues around margins, consumer demand, and acquisition integration. At the same time, the company remains profitable, has a low valuation, and is led by a CEO we still view as a strong capital allocator.

sIF Backlog Visibility, and Operating Leverage

Sifco Industries, Inc. (NYSE:SIF) (aerospace metal forgings) remained one of the favorites from the Open Forum. The company was added to the Focus Model Portfolio last month after a second consecutive strong quarter that showed revenue growth, gross margin expansion, and meaningful operating leverage.

The key KPI (key performance indicator) we focused on was backlog. Backlog has increased significantly over the past year and remains well above current revenue levels. Management has also indicated that a substantial portion of the backlog is expected to be fulfilled within the following 12 months.

That creates a setup where the current revenue and EPS trajectory may have more visibility than the market is giving it credit for. We also discussed how defense program momentum could support continued contract awards and help sustain the backlog story.

Data Center and Infrastructure Threads

The discussion also covered several companies with exposure to infrastructure, power, cooling, or data center-related demand. Hammond Manufacturing Company L (OOTC:HMFAF) (TSX:HMM-A) (electrical enclosures) was discussed as a company with a supply chain and distribution advantage, even if the product set itself is not highly differentiated.

Tecogen Inc. (NYSE:TGEN) (natural gas cogeneration equipment) remained one of the more speculative names tied to data center cooling. The key development was Vertiv moving from a potential demonstration setup on Tecogen Inc. (NYSE:TGEN)’s premises to purchasing a one-megawatt chiller for its own facility.

Tutor Perini Corporation (NYSE:TPC) (civil construction contractor) was also discussed as a construction company with data center exposure and lingering legacy legal issues. The stock had pulled back after its quarter, but the call included commentary around data center opportunities and visibility into 2027.

Information Arbitrage Across Small Companies

A major theme of the Open Forum was information arbitrage in small companies. We used Sifco Industries, Inc. (NYSE:SIF) as an example because its backlog momentum was not clearly highlighted in the press release but could be found by digging into the filings.

Nortech Systems Incorporated (NASDAQ:NSYS) (electronics manufacturing services) was another example. The company made a small reference tied to drone technology in its Q1 earnings call, which later became more relevant after increased attention around the Trump administration’s intent to make drone-related investments. after a muted reaction to its Q1 report, NSYS initially surged as much as 29% in the following days amid reports that the Trump administration was exploring funding for domestic drone companies, before giving back some gains to close last Friday’s session up about 14%.

Tecogen Inc. (NYSE:TGEN), Tutor Perini Corporation (NYSE:TPC), Phonex Holdings, Inc. (OTCID:PXHI), Flexible Solutions Internationa (NYSE:FSI), and Richardson Electronics, Ltd. (NASDAQ:RELL) were also discussed through an information arbitrage lens. In each case, the focus was on finding details in calls, filings, or smaller disclosures that may not yet be fully reflected in the stock.

Toyo Co., Ltd (NASDAQ:TOYO) Due Diligence and the China Question

The Toyo Co., Ltd (NASDAQ:TOYO) (solar supply chain) portion brought in Jev’s research following the May 27 Skull Session with Rhone Resch, Chief Strategy Officer of TOYO Solar. Jev walked through the bull case, including strong revenue growth, margin improvement, a low earnings multiple, and potential tax credit upside.

At the same time, the conversation stayed balanced. The main open issue was whether China-related sourcing, rules of origin, or anti-dumping and countervailing duty questions could affect the thesis.

That is the kind of risk that can change the entire setup if it goes the wrong way. We agreed that more due diligence is needed to understand the sourcing issue, how it connects to Ethiopian operations, and whether the company’s explanation fully addresses the concern.

If you missed the live June Open Forum, the full replay is now available on the GeoInvesting Pro Portal.


If you enjoy performing press release research or think you will see value in a tool that expedites your press release research process, you should check out a press release tool my team is building by going here.

Coverage Universe Stats: Big Movers & Losers and New Highs & Lows

A useful research resource for identifying potentially undervalued momentum stocks and beaten-down names that may rebound over time.

Weekly Top Gainers and Losers

These are the top 10 stocks with the largest overall gains and losses for the entire week.

  • Top 10 Gainers – Weekly (June 1, 2026 – June 5, 2026)

  • Top 10 Losers – Weekly (June 1, 2026 – June 5, 2026)

New 52-Week Highs and Lows

These are stocks that reached new 52-week highs or lows during the week.

  • New 52-Week Highs

  • New 52-Week Lows

[/MM_Member_Decision]


——

Sorry, the full post is only available for paying subscribers. If you are already a paying subscriber, please make sure you are logged in. To become a paying subscriber please click on the link below
(We also offer a new very popular monthly subscription option).
gain Exposure to our expanded coverage on Our 1500+ Microcap Universe, Subscribe below.

200+ multibaggers and counting



GeoInvesting is a premier research platform for microcap investors, dedicated to uncovering high-potential stock ideas in undervalued companies across various sectors. With over 30 years of investing experience, GeoInvesting has covered more than 1,500 equities, providing often actionable proprietary research. The platform has been instrumental in identifying 200+ multibagger stocks, and offers investors exclusive access to over 600 management interview clips, allowing for deeper due diligence and understanding of the microcap stocks, many of which make it to market-beating premium Model Portfolios. Join the GeoInvesting community for the best stock research and microcap insights to help you stay ahead in the market. To learn more about our Premium Services, go here.. (https://geoinvesting.com/premium-research/)

The post Model Portfolio 🚨: Will SYRA Qualify As GeoInvesting’s Next Run to $1.00 Addition? [GeoWire Weekly No. 242] appeared first on GeoInvesting.


Source: https://geoinvesting.com/model-portfolio-will-syra-qualify-as-geoinvestings-next-run-to-1-00-addition-geowire-weekly-no-242/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login